Background Catecholamines have been shown to aggravate atherosclerosis
in animals and humans, and abnormal proliferation of vascular smooth
muscle cells (VSMC) is a key event in the early stage of atheroscleros
is. Catecholamines may be involved in such cell growth. Therefore, a s
eries of experiments using cultured VSMC was performed to elucidate th
eir possible mitogenic effect. Methods and Results We examined the mit
ogenic effect of catecholamines using rat aortic smooth muscle cells (
VSMC) by measuring [H-3]thymidine incorporation, checking with flow cy
tometry, and counting the cell number directly. Furthermore, the catec
holamine-activated signal transduction pathway was assessed by measure
ment of the formation of inositol I, 4,5-triphosphate, intracellular C
a2+ concentration, mitogen-activated protein kinase (MAPK) activity, a
nd mitogenic gene expression. Norepinephrine (NE) and phenylephrine st
imulated [H-3]thymidine incorporation and cell growth. Clonidine and i
soproterenol showed little of such effects. Prazosin was more effectiv
e than either yohimbine or propranolol in suppressing the mitogenic ef
fect of NE, indicating that catecholamine-induced VSMC proliferation i
s mediated by alpha(1)-adrenoceptors. The alpha(1)-adrenoceptor activa
tion was coupled to pertussis toxin-insensitive G(q)-protein and trigg
ered phosphoinositide hydrolysis with subsequent activation of protein
kinase C and MAPK in VSMC. In response to NE, both 42- and 44-kD MAPK
were activated and tyrosine was phosphorylated. alpha(1)-Adrenoceptor
stimulation with NE also caused accumulation of c-fos, c-jun, and c-m
yc mRNA. Chloroethylclonidine completely blocked the alpha(1)-adrenoce
ptor-mediated mitogenesis. Conclusions The effect of catecholamines ap
pears to be mediated via the activation of the chloroethylclonidine-se
nsitive alpha(1)-adrenoceptors that triggers the phosphoinositide hydr
olysis and activates the MAPK pathway, leading to DNA synthesis and ce
ll proliferation.